Pharmaceutical - Mergers & Acquisitions, Boehringer Ingelheim

Filter

Popular Filters

Boehringer Ingelheim Venture Fund invests in Eyevensys

15-04-2013

Paris, France-based Eyevensys, a developer of a new process for non-viral gene therapy using electrotransfer…

Boehringer IngelheimEyevensysFinancialMergers & AcquisitionsOphthalmicsPharmaceutical

Back to top